Isofagomine D-Tartrate
中文名称 | Isofagomine D-Tartrate |
---|---|
中文同义词 | 阿戈司他 D-酒石酸盐;化合物 T19182;化合物 AFEGOSTAT D-TARTRATE;(3R,4R,5R)-5-(羟甲基)-3,4-哌啶二酮(2S,3S)-2,3-二羟基丁二酸酯 |
英文名称 | Isofagomine D-Tartrate |
英文同义词 | (3R,4R,5R)-5-(Hydroxymethyl)-3,4-piperidinediol (2S,3S)-2,3-Dihydroxybutanedioate;Isofagomine D-Tartrate;Afegostat D-Tartrate (Synonyms: D-Isofagomine (D-Tartrate);Afegostat D-Tartrate (D-Isofagomine (D-Tartrate);D-Isofagomine D-Tartrate;Isofagomine tartrate;Afegostat DTartrate,Afegostat D Tartrate |
CAS号 | 957230-65-8 |
分子式 | C10H19NO9 |
分子量 | 297.26 |
EINECS号 | |
相关类别 | 制剂-抑制剂;Chiral Reagents;Intermediates & Fine Chemicals;Pharmaceuticals |
Mol文件 | 957230-65-8.mol |
结构式 |
Isofagomine D-Tartrate 性质
熔点 | 124-126°C |
---|---|
储存条件 | -20°C Freezer, Under Inert Atmosphere |
溶解度 | 溶于DMSO(高达2mg/ml) |
形态 | 固体 |
颜色 | 米白色 |
稳定性 | 可在-20°C下的DMSO溶液保存长达1个月。 |
GCase
Vivo: Afegostat (AT2101) increases GCase activity in brain, liver, and spleen. Afegostat (100 mg/kg) administrates orally for 4 months to Thy1-aSyn mice improved motor and nonmotor function, abolishes microglial inflammatory response in the substantia nigra, reduces α-synuclein immunoreactivity in nigral dopaminergic neurons, and reduces the number of small α-synuclein aggregates, while increasing the number of large α-synuclein aggregates.